ARIAD to Present at the Cowen and Company 35th Annual Health Care Conference
February 24 2015 - 7:35AM
Business Wire
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that
it will present at the Cowen and Company 35th Annual Health Care
Conference being held in Boston. Harvey J. Berger, M.D., chairman
and chief executive officer, will provide an overview of the
Company’s business on Monday, March 2, at 2:10 p.m. (ET).
The ARIAD presentation will be webcast live and can be accessed
by visiting the investor relations section of the Company's website
at http://www.ariad.com/investor. A replay of the presentation will
also be available and archived on the site for three weeks.
About ARIAD
ARIAD Pharmaceuticals, Inc., headquartered in
Cambridge, Massachusetts and Lausanne, Switzerland, is an
integrated global oncology company focused on transforming the
lives of cancer patients with breakthrough medicines. ARIAD is
working on new medicines to advance the treatment of various forms
of chronic and acute leukemia, lung cancer and other
difficult-to-treat cancers. ARIAD utilizes computational and
structural approaches to design small-molecule drugs that overcome
resistance to existing cancer medicines. For additional
information, visit http://www.ariad.com or follow ARIAD on Twitter
(@ARIADPharm).
ARIAD Pharmaceuticals, Inc.For InvestorsKendra Adams,
617-503-7028Kendra.adams@ariad.comorFor MediaLiza Heapes,
617-621-2315Liza.heapes@ariad.com
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Sep 2024 to Oct 2024
Ariad (NASDAQ:ARIA)
Historical Stock Chart
From Oct 2023 to Oct 2024